Protective variant for hippocampal atrophy identified by whole exome sequencing

We used whole‐exome sequencing to identify variants other than APOE associated with the rate of hippocampal atrophy in amnestic mild cognitive impairment. An in‐silico predicted missense variant in REST (rs3796529) was found exclusively in subjects with slow hippocampal volume loss and validated usi...

Full description

Saved in:
Bibliographic Details
Published inAnnals of neurology Vol. 77; no. 3; pp. 547 - 552
Main Authors Nho, Kwangsik, Kim, Sungeun, Risacher, Shannon L., Shen, Li, Corneveaux, Jason J., Swaminathan, Shanker, Lin, Hai, Ramanan, Vijay K., Liu, Yunlong, Foroud, Tatiana M., Inlow, Mark H., Siniard, Ashley L., Reiman, Rebecca A., Aisen, Paul S., Petersen, Ronald C., Green, Robert C., Jack Jr, Clifford R., Weiner, Michael W., Baldwin, Clinton T., Lunetta, Kathryn L., Farrer, Lindsay A., Furney, Simon J., Lovestone, Simon, Simmons, Andrew, Mecocci, Patrizia, Vellas, Bruno, Tsolaki, Magda, Kloszewska, Iwona, Soininen, Hilkka, McDonald, Brenna C., Farlow, Martin R., Ghetti, Bernardino, Huentelman, Matthew J., Saykin, Andrew J.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.03.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0364-5134
1531-8249
1531-8249
DOI10.1002/ana.24349

Cover

More Information
Summary:We used whole‐exome sequencing to identify variants other than APOE associated with the rate of hippocampal atrophy in amnestic mild cognitive impairment. An in‐silico predicted missense variant in REST (rs3796529) was found exclusively in subjects with slow hippocampal volume loss and validated using unbiased whole‐brain analysis and meta‐analysis across 5 independent cohorts. REST is a master regulator of neurogenesis and neuronal differentiation that has not been previously implicated in Alzheimer's disease. These findings nominate REST and its functional pathways as protective and illustrate the potential of combining next‐generation sequencing with neuroimaging to discover novel disease mechanisms and potential therapeutic targets. Ann Neurol 2015;77:547–552
Bibliography:istex:CC9D7340BC2A4FC80FD4C516157438D094DA7D5D
ark:/67375/WNG-FGWTQB58-Z
ArticleID:ANA24349
http://adni.loni.usc.edu/wp‐content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at
Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database
adni.loni.usc.edu
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0364-5134
1531-8249
1531-8249
DOI:10.1002/ana.24349